Sort
51,593 grants matching “hepatitis”
The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency
$718,779Shilpa J Buch · University Of Nebraska Medical Center · R01 · FY2020 · DA
Intensive Models of HCV Care for Injection Drug Users
$718,774Alain Litwin · Albert Einstein College Of Medicine · R01 · FY2013 · DA
HEPATITIS B AND C AMONG HOMELESS ADULTS
$718,703University Of California Los Angeles · R01 · FY2002 · DA
The study of neuro-vascular interactions in the central nervous system
$718,584Yoh-Suke Mukouyama · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B
$718,565Stewart Cooper · California Pacific Med Ctr Res Institute · R01 · FY2023 · DK
Newborn cohorts to discover and validate biomarkers of neonatal vaccine immunogenicity
$718,534Ofer Levy · Boston Children'S Hospital · U19 · FY2017 · AI
The Impact of HCV Infection on Bone Turnover, Density, and Strength
$718,442Todd T Brown · Johns Hopkins University · R01 · FY2019 · AI
Functions of vitamin E and the tocopherol transfer protein
$718,422Danny Manor · Case Western Reserve University · R01 · FY2021 · DK
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$718,413David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
CVD in American Indians Biomarker lab and Arizona Field Center
$718,329Jason G Umans · Medstar Health Research Institute · R01 · FY2017 · HL
CVD in American Indians Biomarker lab and Arizona Field Center
$718,329Jason G Umans · Medstar Health Research Institute · R01 · FY2016 · HL
MR-Image Guided Focused Ultrasound for Treatment of Liver and Renal Cancer
$718,295Kim Butts Pauly · Stanford University · R01 · FY2012 · CA
Sickle Cell Disease and Sickle Cell Trait Protection Against HIV-1-infection in Africans and African Americans
$718,249Sergei Nekhai · Howard University · R01 · FY2020 · HL
Alcohol Metabolism, Functional Consequence And Signaling Mechanism
$718,210Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · Z01 · FY2008 · AA
Countermeasures Against Chemical Threats: Countermeasures Against Cyanide
$718,138Steven E Patterson · University Of Minnesota · U01 · FY2010 · NS
Integrated approaches to close the loop in type 1 diabetes
$717,961Yogish C. Kudva · Mayo Clinic Rochester · R01 · FY2013 · DK
US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)
$717,894Juliet Iwelunmor · Washington University · U54 · FY2025 · CA
SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
$717,833Michael Agus · Boston Children'S Hospital · R01 · FY2008 · HL
New Approaches To Passive Immunoprophylaxis
$717,699Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Control of Autoimmunity by Regulatory T Cells
$717,622Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Computation and Repurposing to identfy antivirals directed against dominant
$717,597Vijay S Pande · Stanford University · U19 · FY2014 · AI
Molecular Magnetic Resonance of Hepatic Fibrogenesis
$717,569Peter D Caravan · Massachusetts General Hospital · R01 · FY2024 · DK
Mobile Phone Enabled HIV Prevention and Treatment Interventions for Health Disparity Populations in South Los Angeles
$717,500Jaydutt V Vadgama · Charles R. Drew University Of Med & Sci · U54 · FY2021 · MD
Development of caspase-6 inhibitors for treatment of NASH
$717,397Alan R. Saltiel · University Of California, San Diego · R01 · FY2023 · DK
Bay Area Hepatitis C Cooperative Research Center
$717,263Joseph M McCune · University Of California, San Francisco · U19 · FY2012 · AI